[63C1-63C1];[63D1-63D1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
63C1;63D1
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3L)1227.
Presence of P+PBac{XP5.WH5}BSC129 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(3L)BSC129 predicted from the transposable element insertions sites are 63C1;63D1.